Prior authorization challenges persist in U.S. healthcare

Prior authorization remains a significant administrative and financial challenge within the United States healthcare system, accounting for an estimated $35 billion in administrative spending. The process, used by payers to determine medical necessity before services are rendered, often leads to delays; the American Medical Association reports that 94% of patients experience care delays and 78% abandon treatment entirely.

While the process is frequently criticized by physicians, patients, and drug companies, some argue it serves as a necessary checkpoint against low-value care. The debate highlights a tension between administrative burden and the need to prevent unnecessary, duplicative, or unsupported medical spending.

Efforts to reform the system are increasingly focused on automation and modernization. However, experts suggest that meaningful progress requires more than new interfaces; it necessitates scaling solutions across the broader ecosystem to move beyond manual processes like phone calls, faxes, and individual portals. Existing HIPAA-mandated transaction standards, such as the X12 implementation guide, provide a foundation for these technological improvements.